Craig McCoy, DO
Obstetrics & Gynecology · Moberly, MONPI 1053312017
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $86,125 of the $101,410 with a category attached, or 84.9%. 17 manufacturers reported payments, led by Coopersurgical, Inc. at 56.8% of the total. Reporting peaked in 2019 at $37,142 and has fallen 99.7% since, to $107 in 2025. Among obstetrics & gynecology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $724.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopersurgical, Inc.$58K
- Apyx Medical Corporation$40K
- Medtronic$2K
- Intuitive Surgical$1K
- Allotrope Medical, Inc$182
- Axonics, Inc.$97
- plus $300 from 11 others
Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Northgate Technologies, Inc.$500
What the payments were for
- Consulting fees$86,12585%
- Speaking & faculty fees$4,7505%
- Travel & lodging$6,8087%
- Food & beverage$3,6774%
- Gifts$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopersurgical, Inc. | 46 | $57,627 |
| Apyx Medical Corporation | 30 | $40,085 |
| Medtronic(2 entities) | 36 | $2,108 |
| Intuitive Surgical | 8 | $1,011 |
| Allotrope Medical, Inc | 2 | $182 |
| Axonics, Inc. | 3 | $97 |
| Pfizer | 4 | $66 |
| Caldera Medical, Inc | 2 | $65 |
| Dexcom, Inc. | 1 | $34 |
| AbbVie | 1 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| Resmed Corp | 1 | $20 |
| Boston Scientific | 1 | $16 |
| Conmed Corporation | 1 | $15 |
| Dysis Medical, Inc. | 1 | $13 |
| Ascend Therapeutics US, LLC | 1 | $12 |
| Hologic Sales And Service, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endosee$48,313
- Uterine Manipulators & Injectors$7,000
- INTERSTIM$1,238
- Mara Console$1,058
- Da Vinci Surgical System$877
- Summit Doppler$430
- WALLACH Cryosurgical Equipment$419
- StimSite$103
How this compares
$101,410 in reported general payments places this provider in the 95th percentile of 750 obstetrics & gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 52 | $31,551 |
| GemtesaVibegron | 43 | $26,627 |
| Methenamine Hippurate | 69 | $3,524 |
| PremarinEstrogens, Conjugated | 13 | $3,376 |
| CombipatchEstradiol/Norethindrone Acet | 11 | $2,683 |
| Tolterodine Tartrate ErTolterodine Tartrate | 37 | $1,758 |
| Oxybutynin Chloride ErOxybutynin Chloride | 79 | $1,757 |
| Estradiol | 62 | $1,673 |
| Clobetasol Propionate | 16 | $1,317 |
| Solifenacin Succinate | 23 | $1,062 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 61 | $998 |
| Desmopressin Acetate | 19 | $570 |
| Hydroxyzine Hcl | 14 | $510 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 14 | $457 |
| Medroxyprogesterone Acetate | 16 | $396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $23 | $31,55152 claims |
| PfizerPremarin | $66 | $3,37613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 750 obstetrics & gynecology providers in Missouri.
Other obstetrics & gynecology in Moberly
- Thomas ShultzSpringfield$1.1M
- Becky LynnSaint Louis$231K
- Timothy HallIndependence$172K
- Richard GutknechtIndependence$65K
- Amanda CarrollFestus$55K
- Amy CarterKansas City$49K
- Megan SneedLees Summit$44K
- Kimberly LemoineSaint Louis$30K
- Carrie CardaPoplar Bluff$22K
- John McCarvilleBranson$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.